Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-08-25 | New | $84,999,985 | Unknown | Equity Only | SEC link | |
2023-06-01 | New | $65,015,462 | $65,015,462 | Equity Only | 06b | SEC link |
2022-07-19 | New | $55,749,999 | $55,749,999 | Equity Only | 06b | SEC link |
2017-12-04 | New | $20,000,000 | $20,000,000 | Equity Only | 06c | SEC link |
2017-05-08 | New | $45,539,314 | $45,539,314 | Equity Only | 06b | SEC link |
2016-04-27 | New | $15,007,220 | $15,007,220 | Equity and Debt | 06b | SEC link |
2015-12-30 | New | $4,000,000 | $4,000,000 | Debt Only | 06b | SEC link |
2015-06-05 | Amended | $20,000,000 | $7,000,001 | Equity Only | 06b | SEC link |
2014-08-11 | Amended | $12,999,999 | $0 | Equity Only | 06b | SEC link |
2013-08-13 | New | $12,999,999 | $12,999,999 | Equity Only | 06 | SEC link |
2011-02-07 | New | $9,600,002 | $9,600,002 | Equity Only | 06 | SEC link |
2010-09-24 | New | $400,002 | $400,002 | Equity Only | 06 | SEC link |
Name | Role |
---|---|
Jan Adams | Director |
William Aliski | Director |
Errik B Anderson | Director, Executive |
Christophe Arbet Engels | Executive |
Mark Baldry | Executive |
Robert L. Birnbaum | Executive |
Gary J. Bridger | Director |
Dan Burgess | Director |
Daniel Burgess | Director |
Diego Cadavid | Executive |
William Clark | Director |
Adam Craig | Director, Executive |
Francoise De Craecker | Director |
Mary Di Biase | Executive |
Tillman U. Gerngross | Director |
Carl Gordon | Director |
Michael Gray | Executive |
David Kirske | Executive |
Alison Lawton | Director |
David Mantus | Executive |
David Mc Girr | Director |
Terrance Mc Guire | Director |
Derek Meisner | Executive |
Adam Mostafa | Executive |
Eszter Nagy | Executive |
Claudio Nessi | Director |
Paula Ragan | Director, Executive |
Michael Ross | Director |
Rene Russo | Director, Executive |
Amy Schulman | Director |
Chris Stevens | Executive |
Murray W. Stewart | Director |
Arthur Taveras | Executive |
John Volpone | Executive |
Michael S. Wyzga | Director |